ablation - search results
If you're not happy with the results, please do another search
Arrhythmia mapping system improves freedom from AF during ablation
Vektor Medical has announced that use of the vMap arrhythmia mapping system during complex atrial fibrillation (AF) ablation was associated with significantly improved freedom...
Medtronic receives CE Mark approval for Affera mapping and ablation system to treat arrhythmias
Medtronic has announced today that it has received CE Mark for the Affera mapping and ablation system, which includes the Sphere-9 catheter and the...
Low BMI associated with cardiac tamponade during catheter ablation for atrial fibrillation
A recent analysis of a large nationwide database of patients with atrial fibrillation (AF) who underwent ablation has reported an independent association between being...
Dual energy AF ablation catheter begins evaluation in SmartfIRE clinical trial
Biosense Webster has announced the first cases with its investigational Thermocool Smarttouch SF dual energy catheter have taken place as part of the SmartfIRE...
Inpatient AF ablation associated with early mortality and post-procedure complications, study finds
Atrial fibrillation (AF) ablation carried out in an inpatient setting is associated with higher rates of early mortality and subsequent complications when compared with...
Abbott announces European and US approvals for ablation technologies
Abbott has today announced receipt of the CE mark for the TactiFlex ablation catheter, sensor enabled (SE), alongside US Food and Drug Administration (FDA)...
Varian receives IDE for RADIATE-VT cardiac radioablation clinical trial
Varian, associated with Siemens Healthineers, announced today that the US Food and Drug Administration (FDA) approved an investigational device exemption (IDE) for the pivotal...
Systematic review and meta-analysis finds P-wave duration to increase risk of AF recurrence after...
In their updated meta-analysis of 4,175 patients, Stergios Intzes together with a team from the Democritus University of Thrace, Alexandroupoli, Greece and the Heart...
Medtronic completes enrolment in pulsed field ablation catheter trial for patients with AF
Medtronic has announced enrolment completion and final treatment in the SPHERE Per-AF, a US Food and Drug Administration (FDA) Investigational Device Exemption (IDE) trial....
Catheter ablation shown to reduce mortality and hospitalisation in patients with atrial fibrillation and...
An analysis of randomised controlled trials (RCTs) has found catheter ablation reduces mortality and heart failure hospitalisations in patients with atrial fibrillation (AF) and...
Study compares risk of dementia in AF patients undergoing catheter ablation versus drug-therapy
Biosense Webster has announced the publication of data from a study comparing the risk of dementia in patients with atrial fibrillation (AF) who were...
Ablation as first-line treatment cuts AF progression compared to antiarrhythmic drugs
Ablation as a first-line treatment for atrial fibrillation (AF) disease is associated with significantly better clinical outcomes than starting with antiarrhythmic drugs.
These were the...
First patients treated in study of Globe pulsed field ablation system
Kardium has announced the successful first-in-human study of its next generation Globe pulsed field system to treat atrial fibrillation (AF) using pulsed field ablation...
Catheter ablation of AF “increased cerebral blood flow”, observational study finds
Catheter ablation of atrial fibrillation (AF) has favourable effects on cerebral blood flow, particularly in non-paroxysmal AF, research published in JACC: Clinical Electrophysiology.
The results...
Heliostar radiofrequency balloon ablation catheter gets European launch
Biosense Webster has announced the European launch of the Heliostar radiofrequency balloon ablation catheter. Heliostar is indicated for use in catheter-based cardiac electrophysiological mapping...
AtriAN initiates second trial of pulsed field ablation in cardiothoracic surgery patients with paroxysmal...
AtriAN Medical has announced that it has completed enrolment of a second study using its selective pulsed field ablation (PFA) technology for the treatment...
FDA approves clinical trial of SERF ablation for VT patients
Thermedical has announced that the US Food & Drug Administration (FDA) has approved an open-label, single-arm interventional clinical trial to evaluate the safety and...
First-in-man study yields promising results for saline-enhanced radio frequency VT ablation
A first-in-human multicentre trial using in-catheter, heated saline-enhanced radio frequency (SERF) ablation for patients with ventricular tachycardia (VT) has reported that the technique showed...
Catheter ablation “economically attractive” compared to drug therapy for AF
Catheter ablation of atrial fibrillation (AF) was economically attractive compared with drug therapy in the CABANA (Catheter ablation versus antiarrhythmic drug therapy for atrial...
HRS 2022: Registry data support role of cardioneural ablation to address vasovagal syncope
Findings of the US multicentre cardioneural ablation (CNA) registry were presented during a late-breaking clinical trial session at the Heart Rhythm Society’s 2022 annual...
HRS 2022: Same day discharge “benefits AF ablation patients”
Results of a study presented at the Heart Rhythm Society’s 2022 annual meeting (HRS 2022, 29 April–1 May, San Francisco, USA) show that the...
Early experience shows benefit to high-power short-duration AF ablation
The use of high-power, short duration ablation for atrial fibrillation (AF) has the potential to speed up procedural times and increase the number of...
AF Symposium 2022: Latest evidence for lattice tip catheter ablation strategies shared
Pulsed-field ablation (PFA) and/or radiofrequency ablation (RFA) using a lattice-tip catheter can both isolate pulmonary veins (PVs) and create linear lesions efficiently and safely,...
Same-day discharge for catheter ablation of atrial fibrillation deemed safe and feasible
A recent systematic review and meta-analysis, published in the Journal of Interventional Cardiac Electrophysiology, has deemed same-day discharge following catheter ablation of atrial fibrillation...
New data underpin drive towards earlier AF ablation strategies
Historically, catheter ablation has been reserved for atrial fibrillation (AF) patients who have failed to respond to, or tolerate antiarrhythmic drug therapy, electrophysiologist Dhiraj...
Hot balloon ablation and cryoballoon ablation deemed effective for AF treatment
Both cryoballoon ablation (CBA) and hot balloon ablation (HBA) are effective treatment options for atrial fibrillation (AF), however, patients treated with HBA are more...
Freezor cardiac cryoablation catheters approved to treat paediatric AVNRT
Medtronic has announced that the Freezor and Freezor Xtra cardiac cryoablation catheters are approved by the US Food and Drug Administration (FDA) to treat...
Q-FFICIENCY trial shows promise for temperature-controlled ablation
Use of temperature-controlled ablation for the treatment of atrial fibrillation (AF) is effective and highly efficient, according to Jose Osorio—the director of electrophysiology at...
Study shares success of complete PVI using only pulsed field ablation
A recent study has demonstrated 100% pulmonary vein isolation (PVI) using only pulsed field ablation (PFA), resulting in no PFA-related serious adverse events. This...
Contact force-guided ablation for typical atrial flutter does not reduce recurrent atrial arrhythmia
Contact-force (CF)-guided ablation to treat typical atrial flutter does not reduce recurrent atrial arrhythmia at 12 months follow-up, in comparison to ablation blinded for...
Khaldoun Tarakji joins Medtronic’s cardiac ablation division
Khaldoun Tarakji, associate section head of cardiac electrophysiology at the Heart, Vascular, and Thoracic Institute at Cleveland Clinic (Cleveland, USA) has joined Medtronic as...
First patients treated using Adagio Medical’s pulsed field cryoablation system
Adagio Medical has announced first-in-human cases of pulsed field cryoablation (PFCA) for the treatment of atrial fibrillation (AF).
The cases were performed at Medicover Hospital,...
First US hospitals to treat patients using AI ablation software
Volta Medical has announced the introduction of VX1 artificial intelligence (AI) software at three US hospitals. New York Presbyterian Queens, Northwell Health’s Lenox Hill...
Patients undergoing robotic ablation found to have reduced incidence of silent cerebral embolism
Stereotaxis has announced the publication of the results of a prospective, multicentre study comparing the incidence of silent cerebral embolism (SCE) in atrial fibrillation...
Pulsed field ablation poised to revolutionise the treatment of atrial fibrillation
The advent of pulsed field ablation (PFA) will revolutionise the treatment of atrial fibrillation (AF), Tom de Potter (Aalst, Belgium) tells Cardiac Rhythm News,...
Study shows safety and efficacy of robotic-guided ablation to treat paediatric arrhythmias
Stereotaxis has announced publication of a study in the International Journal of Cardiology: Heart & Vascular demonstrating superior safety and efficacy of Stereotaxis’ robotic...
Vascade MVP vascular closure system gains same-day discharge labelling for AF ablation
Haemonetics Corporation has announced that the Vascade MVP venous vascular closure system is has received a US Food and Drug (FDA) indication for same-day...
First post-approval procedures performed using Heliostar balloon ablation catheter
Biosense Webster, part of the Johnson & Johnson Medical Devices Companies has announced post-approval procedures were successfully performed with the Heliostar radiofrequency balloon ablation...
APAF-CRT: Ablation and CRT beat drug therapy in permanent AF patients with narrow QRS
Ablation plus cardiac resynchronisation therapy (CRT) is superior to pharmacological rate control in reducing mortality in severely symptomatic permanent atrial fibrillation (AF) patients with...
Targeting atrial fibrosis in AF patients with low levels of disease “may help improve...
Image-guided fibrosis ablation in addition to pulmonary vein isolation (PVI) does not improve ablation success rates compared to PVI alone in patients with persistent...
HRS 2021: CABANA analysis points to economic case for catheter ablation
A new analysis of the CABANA (Catheter ablation versus antiarrhythmic drug therapy for atrial fibrillation) suggests that catheter ablation offers positive economic outcomes compared...
HRS 2021: Early VT catheter ablation beats medical therapy in patients at risk for...
Results of the PAUSE-SCD trial show a significant reduction in risk of ventricular tachycardia (VT) recurrence, cardiovascular hospitalisation, and death when catheter ablation is...
CABANA trial shows favourable results for catheter ablation among ethnic minority patients
Among racial or ethnic minority patients enrolled in the North American cohort of the CABANA (Catheter ablation versus antiarrhythmic drug therapy for atrial fibrillation)...
Adagio’s ultra-low temperature cryoablation system in first-in-human use
Adagio Medical has announced successful first-in-human use of ultra-low temperature cryoablation (ULTC) for the treatment of monomorphic ventricular tachycardia (VT).
The two-hour mapping and ablation...
AHA statement on AF and HFrEF positive for catheter ablation
The American Heart Association (AHA) has this week issued a scientific statement on the management of atrial fibrillation (AF) in patients with heart failure...
Expanded FDA approval for Medtronic’s Arctic Front cryoablation catheter
Medtronic has received US Food and Drug Administration (FDA) expanded approval for the Arctic Front family of cardiac cryoablation catheters for the treatment of...
RAFT-AF fails to show benefit of AF ablation in heart failure patients
Among patients with both heart failure and atrial fibrillation (AF), treatment strategies focused on rhythm control, using catheter ablation, and those focused on rate...
Single-shot pulsed-field ablation yields “excellent” PVI durability
Pulmonary vein isolation (PVI) with a “single-shot” pulsed-field ablation (PFA) catheter results in excellent PVI durability and acceptable safety with a low one-year rate...
Galaxy Medical and Japan Lifeline enter distribution agreement for pulsed electric field focal ablation...
Galaxy Medical (Galaxy) and Japan Lifeline (JLL) have announced an exclusive distribution agreement for the ALPHA1 ablation catheter in the USA, developed by Japan...
CorSystem announces first use of Bipolar Ablation Adapter
CorSystem has announced the first use of its Bipolar Ablation Adapter since the device received CE mark in July 2020.
The patient who underwent treatment...
First patients treated in ADVENT trial of pulsed field ablation system
FARAPULSE has announced that the first patients have been treated in the ADVENT trial, a US Food and Drug Administration (FDA) Investigational Device Exemption...
AF Symposium 2021: Experts debate early ablation strategy in AF
The merits of catheter ablation as a first-line treatment for atrial fibrillation (AF) were considered during the second day of AF Symposium 2021 (29–31...
AF Symposium 2021: HARTCAP-AF supports hybrid over catheter ablation
Hybrid ablation, a procedure which involves “attacking” the atrial substrate from the epicardium and endocardium, has been shown to result in significantly higher freedom...
AF Symposium 2021: Hybrid, multidisciplinary therapy superior to catheter ablation for long-standing persistent AF
Results of a sub-analysis of the CONVERGE clinical trial, presented during a late-breaking trial session at the digital AF Symposium (29–31 January, virtual), suggest...
Medtronic receives FDA approval for DiamondTemp ablation system
Medtronic has received US Food and Drug Administration (FDA) approval for the DiamondTemp ablation (DTA) system which treats patients with recurrent, symptomatic paroxysmal atrial...
Farapulse gains CE mark for its pulsed field ablation system
Farapulse announced that it has received the CE mark for its pulsed field ablation (PFA) system for the treatment of paroxysmal atrial fibrillation (AF)....
Kardium secures financing to advance Globe mapping and ablation system
Kardium has raised US$115 million in a new financing round, which will be used to accelerate commercial growth of the Globe mapping and ablation...
PRECAF study looks at elimination of distal coronary sinus to left atrial connection for...
Elimination of distal coronary sinus (CS) to left atrial (LA) connections reduced atrial arrhythmia recurrences compared to standard pulmonary vein (PV) isolation and non-PV...
CardioFocus announces 10,000-patient milestone for HeartLight ablation system
CardioFocus has announced that more than 10,000 patients worldwide have been treated with the HeartLight endoscopic ablation system.
The HeartLight system is a catheter ablation...
Biotronik receives CE mark for AICath Force ablation catheter
Biotronik has announced CE mark approval for the AlCath Force the gold-tipped force sensing ablation catheter system.
The AlCath Force was designed specifically to show...
Acutus Medical launches the AcQBlate force sensing ablation system in Europe
Acutus Medical has announced the launch of the AcQBlate force sensing ablation system in Europe after securing CE mark for the company’s AcQBlate FORCE...
AHA 2020: Medtronic shares results of cryoablation studies
Medtronic has announced the presentation of results of three studies which it says demonstrate that cryoablation is superior to drug therapy for first-line treatment...
Catheter ablation linked to lower incidence of dementia in AF patients
People with atrial fibrillation (AF) have a reduced risk of dementia if they undergo catheter ablation to restore the normal rhythm of their heart,...
US FDA approves Biosense Webster’s Thermocool Smarttouch SF ablation catheter
Johnson & Johnson Medical Devices Companies has announced the US Food and Drug Administration (FDA) approval of Biosense Webster’s Thermocool Smarttouch SF ablation catheter...
Holographic ablation guidance system gains US FDA clearance
SentiAR has received US Food and Drug Administration (FDA) 510(k) clearance for its CommandEP system, the first holographic guidance system to be used during...
Boston Scientific to invest in pulsed field ablation device developer
Boston Scientific has signed an investment agreement with an exclusive option to acquire Farapulse, a privately-held company developing a pulsed field ablation (PFA) system...
ESC 2020 Congress: STOP AF First finds cryoballoon ablation safer than drug treatment for...
Cryoballoon catheter ablation as a first line treatment for paroxysmal atrial fibrillation (AF) was found to be safer and more effective than anti arrhythmic...
Biosense Webster receives CE mark approval for QDot Micro ablation catheter
Johnson & Johnson Medical Devices has today announced European CE mark approval of Biosense Webster’s QDot Micro radiofrequency (RF) ablation catheter.
According to a press...
Fitness linked to lower arrhythmia recurrence after AF ablation
Patients undergoing atrial fibrillation (AF) ablation, who are physically fit before the procedure, have a much higher chance of benefiting from the procedure and...
Integrated cardiac ablation performed using remote telerobotic system
Stereotaxis and Acutus Medical have announced the first integrated cardiac ablation procedure using remote TeleRobotic support. Gery Tomassoni of Baptist Health, Lexington, USA treated...
Adagio Medical reports pre-clinical success combining cryoablation catheter with pulsed field ablation
Adagio Medical, developer of the intelligent Continuous Lesion Ablation System (iCLAS), has announced successful pre-clinical results demonstrating its existing cryoablation catheter is also capable...
Holographic display may improve physician accuracy during cardiac ablation
Details of the first-in-human use of an augmented reality holographic display to aid physician accuracy during cardiac ablation have been published in the Journal...
Paper highlights use of robotic system for catheter ablation in COVID-19 patients
Stereotaxis has announced the publication of a paper in the European Heart Journal highlighting the benefits of using robotic technology for the management of...
Lower rate of post-ablation arrhythmia recurrence found in patients with shorter AF episodes
Patients with atrial fibrillation (AF) episodes limited to less than 24 continuous hours had a significantly lower incidence of arrhythmia recurrence following AF ablation...
Kardium receives CE mark for its Globe Mapping and Ablation System
Kardium has received CE mark approval for its Globe Mapping and Ablation System for the treatment of atrial fibrillation (AF).
“This is an important milestone...
First US patients treated using HeartLight X3 ablation system
CardioFocus has announced that the first patients have been treated commercially with the recently-approved HeartLight X3 endoscopic ablation system in the USA. The cardiac...
Adagio Medical receives CE mark for iCLAS ablation system
Adagio Medical has received CE mark approval for its ultra-low temperature intelligent Continuous Lesion Ablation System (iCLAS) for the endocardial treatment of paroxysmal (PAF)...
Durablate catheter results demonstrate feasibility in VT ablation
Thermedical has announced that results from a first-in-human early feasibility study (EFS) using the Durablate catheter to treat ventricular tachycardia (VT) were presented in...
US FDA approval granted for HeartLight X3 endoscopic ablation system
CardioFocus has announced that the US Food and Drug Administration (FDA) has approved the next-generation HeartLight X3 endoscopic ablation system for the treatment of...
Contact force sensing catheters “safe and effective” in persistent AF ablation
Contact force (CF) sensing catheters have been shown to be safe and effective in persistent atrial fibrillation (AF) ablation, according to the findings of...
Same-day discharge “feasible for majority of AF ablation patients”
Same-day discharge after atrial fibrillation (AF) ablation is feasible for the majority of patients when a standardised protocol is used, findings of a multicentre cohort study, published in the Journal of the American...
Virtual ACC: Ethanol infusion in vein of Marshall improves catheter ablation outcomes
The infusion of ethanol via the vein of Marshall (VOM), coupled with catheter ablation, leads to improved outcomes for patients with persistent atrial ablation, according to the findings of a study presented by...
Novel lattice tip catheter safe, feasible, and durable in RF ablation
Rapid high-current, temperature-controlled point-by-point pulmonary vein isolation (PVI) and linear ablation has been shown to be clinically feasible and safe in a first-in-human study...
AF Symposium 2020: Cryoablation pulmonary vein isolation is safe and effective for persistent atrial...
Hugh Calkins (Johns Hopkins Medical Institutions, Baltimore, USA) told delegates attending the AF Symposium 2020 (23–25 January, Washington, DC, USA) that cryoablation with the...
AF Symposium 2020: Myocardial specificity of pulsed field ablation provides safety advantage for persistent...
At the AF Symposium 2020 (23–25 January, Washington, DC, USA), Vivek Y Reddy (Helmsley Electrophysiology Center, Icahn School of Medicine at Mount Sinai, New York, USA)...
Hypocapnia could aid ablation of cardiac arrhythmias
A technique that enables patients suffering from heart conditions to hold their breath safely for over five minutes could have potential as a treatment...
Tackling focal VT may improve catheter ablation in structural heart disease
Uncovering and abolishing focal ventricular tachycardia (VT) may further improve outcomes of catheter ablation in the treatment of structural heart disease, a study published...
CardioFocus treats first patients with HeartLight endoscopic ablation system in France
CardioFocus has announced that the first patients in France have been treated in the University Public Hospital of Nancy with the HeartLight endoscopic ablation...
Almost one in 200 patients die early after AF ablation in a real-world analysis...
Early mortality following atrial fibrillation (AF) ablation affects nearly one in 200 patients, with the majority of deaths occurring during 30-day readmission, an analysis...
ESC 2019: Catheter ablation may be up to 10 times more effective than drug...
Results from the Atrial fibrillation progression trial (ATTEST) were presented on 31 August at the European Society of Cardiology (ESC) Congress 2019 in Paris,...
ESC 2019: Guidelines on supraventricular tachycardias underline pivotal role of catheter ablation
The European Society of Cardiology (ESC) unveiled guidelines for treatment of supraventricular tachycardia (SVT) on the opening day of its Congress (ESC 2019; 31...
First-in-human study demonstrates safety and efficacy of QDOT MICRO ablation catheter
Data presented at Heart Rhythm 2019 (8–11 May, San Francisco, USA) and published in JACC: Clinical Electrophysiology indicates that the QDOT MICRO (Biosense Webster),...
HRS 2019: Next-gen cryoballoon ablation system provides “greater personalisation” to operators
Ante Anic (Split, Croatia) discusses the first in-human trial (CRYO-FIM) looking at a novel cryoballoon ablation system for pulmonary vein isolation at HRS 2019...
REAFFIRM trial data show no significant difference between rotor ablation and conventional therapy
Johannes Brachmann (Coburg, Germany) speaks to Cardiac Rhythm News at HRS 2019 about the REAFFIRM trial, which compared the use of rotor ablation versus...
Boston Scientific initiates trial comparing left atrial appendage closure to direct oral anticoagulants for...
According to a press release, Boston Scientific has initiated the OPTION trial to compare safety and effectiveness of the next-generation Watchman FLX left atrial...
Mapping early sites of activation for AF can be used to guide ablation
A stochastic vector-based approach to mapping and ablation of atrial fibrillation (AF) can be used to determine early sites of activation and to guide...
Biomarkers may predict AF after catheter ablation
Researchers have identified a combination of serum biomarkers that is independently associated with higher prevalence of atrial fibrillation, and with increased incidence and recurrence...
High power short duration ablation for atrial fibrillation: Safety and effectiveness
As part of a session on novel mapping and ablation technologies of atrial fibrillation (AF) at the recent AF Symposium in Boston, USA (24–26...
CABANA finds reduced AF and better quality of life after ablation but no reduction...
Catheter ablation for atrial fibrillation leads to a reduction in atrial fibrillation, better quality of life and lower hospitalisations than medical therapy, but does...
First AF patient treated in US IDE study evaluating QDot Micro RF ablation catheter
It was recently announced that Biosense Webster has enrolled and treated the first patient in its US Investigational Device Exemption (IDE) study, which evaluates...
First patient treated in STELLAR US study evaluating next-generation balloon ablation catheter for atrial...
Biosense Webster has enrolled and treated the first patient in its STELLAR US investigational device exemption (IDE) study. The study will evaluate the safety...
First US clinical study to assess ablation for monomorphic ventricular ablation initiated
Abbott has announced the start of LESS-VT—the first US clinical trial to evaluate the safety and effectiveness of ablation treatment for patients with monomorphic...
Adagio Medical treats first atrial fibrillation patients using new One Shot+ cryoablation catheter
Adagio Medical, the developer of the iCLAS technology—the company's ultra-low temperature intelligent continuous lesion ablation system for the treatment of cardiac arrhythmias—announces that the...
New guidelines for cardiovascular disease management during pregnancy: Risk-dependent action plans and upgraded recommendations...
New guidelines for the management of cardiovascular diseases during pregnancy, including upgraded recommendations of catheter ablation and risk-dependent action plans, were presented by Carina...
Procedural EHRA training course on Advanced EP with focus on AF ablation
W: www.escardio.org
Thoracoscopic ablation and left atrial appendage excision found to be superior to catheter ablation...
Symptomatic atrial fibrillation (AF) patients with previous failed catheter ablation or structural changes associated with higher recurrence of AF could benefit from thoracoscopic ablation...
CABANA trial provides important new data on clinical and quality of life effects of...
Catheter ablation for atrial fibrillation (AF) produced no significant improvement in death, disabling stroke, serious bleeding, or cardiac arrest but did reduce death or...
Ultralow temperature ablation: Results from the Cryocure I and Cryocure II trials
The trials found that ultralow temperature cryoablation is feasible and shows excellent safety and efficacy. The clinical outcomes for flutter ablation show a 94%...
Surgical treatment of atrial fibrillation results in higher complication rates when compared to catheter...
The total procedure-related complications after surgical minimally invasive pulmonary vein isolations (MIPI) were higher; this was mainly due to more major complications. During a...
Apixaban is a safe alternative to warfarin during catheter ablation of atrial fibrillation and...
Apixaban and warfarin are equally safe during catheter ablation of atrial fibrillation, according to results of the AXAFA-AFNET 5 (Anticoagulation using the direct factor...
Real-time lesion formation and gap detection during ablation: DURABLE-I follow-up
One-year results from the Dielectric Unravveling of RAdiofrequency ABLation Effectiveness (DURABLE-I) clinical trial have shown that the KODEX (Navix International Limited) system help to...
Case report: Usefulness of high resolution mapping with mini-electrodes to select ablation site...
This article has been sponsored by Boston Scientific.
Case description
A 62-year-old woman, with recent sinus venosus atrial septal defect correction surgery, developed a persistent macroreentrant...
Sheath designed to reduce radiation exposure and improve ablation procedure efficiency launched
The CARTO VIZIGO Bi-directional Guiding Sheath is now available in the United States. This is the first commercially available steerable guiding sheath that can be...
DEEP-guided ablation may enable better treatment of ventricular tachycardia
Results from a multicentre study of catheter ablation guided by DEEP (decrement-evoke potential) mapping show that using DEEP mapping meant that ablation was successful...
Catheter ablation for atrial fibrillation: Lessons and developments
It was a year of big results for catheter ablation, continuing the procedure’s steady rise in atrial fibrillation (AF) management. Mark O’Neill, consultant cardiologist...
Successful ablation for ventricular tachycardia associated with markedly reduced mortality in advanced heart failure...
Wendy Tzou (University of Colorado School of Medicine, Denver, USA) and colleagues at the International Ventricular Tachycardia Ablation Center Collaborative group (IVTCC) published two...
US Patent Office allows AblaCor five ablation catheter-anchoring patents
AblaCor medical corporation has announced that it has received a notice of allowance from the United States Patent & Trademark Office on five additional patents for...
New data demonstrates >90% year 1 success rate for radiofrequency ablation in treating patients...
Biosense Webster, a Division of Johnson & Johnson Medical NV/SA, and a leader in the diagnosis and treatment of cardiac arrhythmias, recently presented new...
Imaging-based simulations for predicting sudden death and guiding ablation
Natalia Trayanova envisions the future of cardiology and electrophysiology advancing through personalised medicine and computational simulations. Trayanova is the director of the Computational Cardiology...
Results of CASTLE-AF trial published: catheter ablation better than conventional drug therapy for atrial...
The results of the CASTLE-AF study, published today in the New England Journal of Medicine, show that patients treated with radiofrequency catheter ablation rather than...
Less bleeding in ablation with interrupted dabigatran compared to uninterrupted warfarin
The results of ABRIDGE-J, a Japanese multicentre randomised study on minimally interrupted dabigatran vs. uninterrupted warfarin for catheter ablation, were presented during a late-breaking...
Imricor announces completion of enrolment for MRI-guided ablations clinical study
Imricor Medical Systems announced today the completion of enrolment for the clinical study to evaluate Imricor’s Vision-MR Ablation Catheter for the treatment of atrial flutter...
Noninvasive radioablation: Radiotherapy shows 99.9% VT burden reduction
A small study by Phillip S Cuculich (Washington University School of Medicine, St Louis, USA) et al has shown that radiation therapy, commonly used...
Imricor announces new developments in MR compatible ablation products
Imricor is developing a magnetic resonance (MR) compatible injection catheter and has announced a joint development agreement with MiRTLE Medical to integrate MiRTLE’s MR...
Measuring outcomes after catheter ablations for AF
Published in the Journal of the American College of Cardiology (JACC): Clinical Electrophysiology, Björkenheim et al’s study of patient- and physician-reported outcomes of atrial...
Catheter ablation lowers mortality in atrial fibrillation patients with heart failure
Catheter ablation of atrial fibrillation significantly reduces mortality and hospitalisation in atrial fibrillation patients with heart failure in comparison with conventional treatment, data from...
ISCAT: 12th International symposium on catheter ablation techniques
W: www.iscat.net
21st Prague Workshop on Catheter Ablation
W: www.ablationworkshop.com
Repeat ablation with contact force sensing “does not necessarily guarantee a successful outcome” in...
Preliminary results from the ABLATOR observational registry have shown similar success rates (around 58%) in first time ablation and repeat ablation for persistent atrial...
CardioFocus receives approval for HeartLight Endoscopic Ablation System in Japan
CardioFocus has announced that the Japanese Ministry of Health, Labour and Welfare has approved the HeartLight Endoscopic Ablation System for the treatment of paroxysmal atrial fibrillation...
Cardiac Insight releases Cardea Solo wearable cardiac monitor for diagnosing AF following cardiac ablation
Cardiac Insight, a US developer of wearable medical devices and diagnostic software, has announced that its US Food and Drug Administration (FDA)-approved Cardea Solo...
Siemens Healthineers and Imricor to partner for 3D MRI-guided cardiac ablation system
Siemens Healthineers is joining forces with Imricor Medical Systems to develop an integrated system that combines the clinical benefits of real-time magnetic resonance imaging...
Rate of early death after ventricular tachycardia ablation as high as 5%
Early post-procedural mortality occurred in 5% of cases of radiofrequency catheter ablation in patients with scar-related ventricular tachycardia (VT), with more than half of...
Medtronic initiates global trial of Arctic Front Advance cardiac cryoablation catheter
Medtronic has enrolled the first participants in the STOP Persistent AF clinical trial. The trial will evaluate the safety and effectiveness of a pulmonary...
Biosense Webster launches Carto 3 system Carto Visitag module with Ablation Index
Biosense Webster has launched of the Carto Visitag module with Ablation Index, a new technology providing visual indication based on the integration of power,...
ACC 2017: Uninterrupted dabigatran performs better than warfarin in atrial fibrillation ablation
Results from the RE-CIRCUIT study have shown that uninterrupted dabigatran (Pradaxa, Boehringer Ingelheim), was associated with fewer bleeding complications than uninterrupted warfarin before, during...
ACC 2017: Anticoagulant treatment may be unnecessary for stroke prevention following ablation for atrial...
For patients with persistent atrial fibrillation or those who are at high risk for recurring atrial fibrillation, catheter ablation is recommended, followed most often...
AF ablation associated with phrenic nerve injury: Is this complication now in our rear...
Phrenic nerve injury is a well-established complication of all types of atrial fibrillation (AF) ablation and is most common with balloon-based approaches, writes Hugh...
US FDA approves expanded indication for Medtronic Freezor Xtra cryoablation catheter
The US Food and Drug Administration (FDA) has approved Medtronic’s Freezor Xtra cryoablation catheter for treating patients with atrioventricular nodal re-entrant tachycardia (AVNRT). The...
Advancements in Persistent AF Ablation: New Clinical Evidence and Techniques
This webinar has been sponsored by Medtronic.
Watch the recent webinar on persistent Atrial Fibrillation (AF) ablation with Prof. Schilling (St. Barts, London), Prof. de...
Multielectrode mapping may be more effective than point-by-point mapping for VT substrate ablation
Results from the first randomised study comparing multielectrode mapping vs. conventional point-by-point mapping for ventricular tachycardia (VT) substrate ablation procedures have shown that a...
STS recommends surgical ablation as an “effective” treatment for atrial fibrillation
The Society of Thoracic Surgeons (STS) has issued new clinical guidelines that include major recommendations for the use of surgical ablation when treating atrial...
Discover the latest evidence and ablation techniques for persistent AF treatment
Join atrial fibrillation (AF) experts Prof Richard Schilling (St Barts Hospital, London UK), Prof Carlo de Asmundis (Universitair Ziekenhuis, Brussels, Belgium) and PD Dr...
In search of innovative technologies for ventricular tachycardia ablation with cryoenergy
A proof-of-concept study has demonstrated that a new cryoablation system, which achieves “much cooler” temperatures than previous cryoablation technologies, is able to create large,...
OSYPKA AG launches HAT500® RF ablation system in Europe
OSYPKA AG has announced the launch of the HAT500® radiofrequency (RF) ablation system in Europe. The device received CE mark in October 2016.
OSYPKA AG,...
Cryoballoon ablation demonstrates lower healthcare system costs compared to radiofrequency ablation
Analyses from the FIRE AND ICE trial has shown lower costs with cryoballoon catheter ablation compared to radiofrequency ablation—related to trial period—as a result...
ESC 2016 Clinical Practice Guidelines describe benefits of cryoballoon ablation and long-term cardiac monitoring
Cryoballoon ablation for patients with diagnosed atrial fibrillation, and long-term cardiac monitoring for survivors of stroke who do not have an established diagnosis of atrial...
Osypka AG launches 8mm gold-tipped Cerablate Flutter ablation catheter
According to a company release, the new device is ideal for maximum voltage guided ablation of atrial flutter.
The Cerablate Flutter is a newly designed...
Relevance of imaging for ventricular tachycardia ablation
Cardiac imaging has emerged as an integral part of mapping and ablation in a variety of complex arrhythmias. Advances in imaging techniques, especially the...
Texas Children’s Hospital is the first paediatric institution in USA to offer magnetic navigation...
Stereotaxis has announced that Texas Children’s Hospital in Houston, USA, has installed the its Niobe ES system, which according to the company, is the only...
Ablation of frequent premature ventricular complex allows safe withholding of ICD implant
Patients with frequent premature ventricular complex and primary prevention implantable cardioverter defibrillator (ICD) indication who undergo ablation may be able to avoid ICD implant,...
Abbott announces positive results for FIRM-guided rotor ablation at CARDIOSTIM 2016
Abbott has announced positive results from three clinical studies investigating the benefits associated with focal impulse rotor modulation (FIRM)-guided rotor ablation for atrial fibrillation.
The...
Fewer repeat ablations and hospitalisations with cryoballoon demonstrated in FIRE AND ICE
New data from the FIRE AND ICE clinical trial have shown significantly fewer repeat ablations and lower hospitalisation rates for patients with paroxysmal atrial...
Catheter ablation is superior to amiodarone in the treatment of patients with heart failure...
New research indicates that catheter ablation may achieve greater long-term freedom from atrial fibrillation, as well as a reduction in unplanned hospitalisation and mortality...
Radiofrequency catheter ablation shows benefits for recurrent ventricular tachycardia patients
A prospective, multicentre study—THERMOCOOL VT—analysing a cohort of non-randomised patients, published in February in the Journal of the American College of Cardiology, has shown...
Cryoballoon ablation for AF may be economically favourable compared with focal radiofrequency ablation
A subsequent study of the Value PVI (pulmonary vein isolation) study report several economic benefits, including reduced staff overtime and more time remaining for...
11th International Symposium on Catheter Ablation Techniques (ISCAT)
W: www.iscat.net
FIRE AND ICE trial results: cryoballoon ablation is non-inferior to radiofrequency ablation
Karl-Heinz Kuck, Asklepios Klinik St Georg, Hamburg, Germany, speaks at ACC 2016 about the FIRE AND ICE trial results which have shown that cryoballoon...
Ventricular tachycardia ablation in Chagas disease
Guilherme Fenelon (Sao Paulo, Brazil) overviews the role of ablation of ventricular tachycardia in Chagas disease. He says: catheter ablation in Chagas disease remains...
First randomised trial shows “poor outcomes” with rotor ablation
OASIS, the first randomised, controlled, multicentre clinical trial to compare rotor-only ablation with two other ablation strategies in non-paroxysmal atrial fibrillation patients found “poor...
Ablation should be “preferred approach” in drug-resistant ventricular tachycardia
A multicentre, randomised controlled trial has shown that catheter ablation is superior to intensified antiarrhythmic drug therapy in reducing death, appropriate implantable cardioverter defibrillator...
Routine ganglionic plexus ablation “should not be performed” in advanced atrial fibrillation patients
Results from the AFACT trial have shown no clinical benefits and significantly more complications associated with routine ganglionic plexus ablation for advanced atrial fibrillation patients. Data were presented at the 37th Heart Rhythm Society Scientific Sessions (HRS; 4-7 May, San Francisco, USA).
AtriCure receives FDA clearance for its cryoFORM cryoablation probe
AtriCure has received US Food and Drug Administration 510(k) clearance for the cryoFORM cryoablation probe, which is designed to offer increased probe flexibility to adapt to a variety of surgical cardiac ablation procedures.
Fluoroscopy times and radiation dose reduced in atrial fibrillation ablation with contact force-sensing technology
A real-world study has found that the SmartTouch (Biosense Webster) contact force-sensing catheter coupled with an Advanced Catheter Location feature during atrial fibrillation (AF) ablation reduced fluoroscopy times by 77%, radiation dose by 71% and procedural time by 19%.
How innovation can unleash tremendous growth in the $3.4 billion AF ablation market
Shlomo Ben-Haim (London, UK), a professor of medicine and serial entrepreneur in the medical device industry, examines the drivers of expansion of the atrial...
Hybrid and surgical atrial fibrillation ablation: Opportunity, threat or both?
Despite major advances in techniques and technology over the past 15 years, the clinical outcomes for catheter ablation in non-paroxysmal atrial fibrillation patients remain...
Stereotaxis begins multicentre, randomised superiority study on ventricular tachycardia ablation outcomes
Stereotaxis has initiated its first prospective, multicentre, randomised clinical study to compare radiofrequency ablation outcomes generated using its Niobe ES remote magnetic navigation system to manual approaches in ischaemic scar ventricular tachycardia (VT) patients.
LuxCath technology demonstrates promising results during first-in-man cardiac ablation procedures
The LuxCath optical tissue interrogation technology was used in eleven patients suffering from arrhythmias such as atrial flutter, AV nodal re-entrant tachycardia, and atrial fibrillation.
Role of rotors in mapping and ablation of ventricular fibrillation
In recently published studies, modulation of rotors by ablation seems to be effective in termination of atrial fibrillation. Now, researchers are exploring the role of rotors in ventricular fibrillation. Siva K Mulpuru (Mayo Clinic, Rochester, USA), discusses the latest research in this field.
AtriCure announces launch of the Cryoform cryoablation probe
Atricure has announced the launch of the Cryoform cryoablation probe, which offers increased probe flexibility to adapt to a variety of surgical ablation procedures.
Westmead Hospital provides data supporting ablation effectiveness of Stereotaxis magnetic navigation
Stereotaxis and Westmead Hospital in Australia have announced findings of a study comparing the stability of a Niobe remote magnetic navigation system catheter group and a manually controlled catheter group in a validated cardiac wall motion simulator.
LuxCath LLC awarded US patent for real-time lesion visualisation technology for AF ablation
The LuxCath LLC system determines electrode-tissue contact as well as monitors lesion progression during ablation and provides real-time lesion visualisation without pressure sensors or ultrasound.
ESC recommends uninterrupted vitamin K antagonists during ablation and device implantation
The recommendations are an update of EHRA's 2008 consensus document, which required an update due to dramatic changes in the field during the last five years.
Advanced technologies to improve efficacy and safety of AF ablation
Technologies to image lesion creation in real time are required to improve the efficacy as well as the safety of atrial fibrillation (AF) ablation....
First patient enrolled in dabigatran study comparing anticoagulation strategies during atrial fibrillation ablation
The study assesses the safety and efficacy of uninterrupted anticoagulation with dabigatran etexilate (Pradaxa) during ablation procedures compared to warfarin. Results from the study are expected during 2016.
Cryoballoon ablation is not as safe as radiofrequency but is as effective
Armin Luik presented findings at HRS 2015 indicating that cryoballoon ablation is a faster as effective as radiofrequency ablation for pulmonary vein isolation in paroxysmal atrial fibrillation patients, but has a greater complication rate and requires higher X-ray dosages.
Adding atrial fibrillation ablation to mitral valve surgery significantly increases risk of permanent pacemaker...
A new study has found that a combination of surgical atrial fibrillation ablation and mitral valve surgery in patients with persistent or long-standing persistent atrial fibrillation is associated with a significantly increased rate of freedom from atrial fibrillation at one year. However, it is also associated with a significantly increased rate of pacemaker implantation.
Catheter ablation superior to amiodarone for patients with persistent atrial fibrillation and heart failure
Speaking at the 2015 American College of Cardiology Annual Scientific Session, Luigi Di Biase reported that-compared with the antiarrhythmic drug amiodarone-catheter ablation significantly increases the rate of freedom of recurrence in patients with persistent atrial fibrillation and heart failure.
First patient enrolled in the GOLD AF registry of Medtronic’s PVAC Gold ablation catheter
Medtronic has announced the first patient enrolment in the GOLD AF registry, a first-of-its-kind, prospective, observational clinical study of its Phased Radiofrequency (RF) Ablation technology for treating patients with symptomatic atrial fibrillation.
St Jude Medical announces FDA approval of FlexAbility Ablation Catheter
The FlexAbility catheter features a handle and shaft combination that allows for improved maneuverability, enabling electrophysiologists to reach challenging anatomic locations within their patients' hearts.
St. Jude Medical begins study of ablation procedures to treat ventricular tachycardia
The FlexAbility ablation catheter will be used to assess benefits of catheter ablation as an adjunctive therapy for patients at risk for life-threatening arrhythmias.
Medtronic initiates European trial to evaluate cryoballoon ablation treatment for atrial fibrillation
Cryoablation creates lesions by freezing tissue in the heart's upper chambers, traditionally around the pulmonary veins, to block the electrical signals that trigger erratic heart rhythms.
Non-invasive mapping prior to ablation may be an effective strategy for persistent atrial fibrillation
Preliminary data from the AFACART study have shown encouraging results when treating persistent atrial fibrillation with non-invasive mapping followed by pulmonary vein isolation and/or linear lesions.
Ventricular tachycardia treatment with robotic catheter ablation shows positive results
A study undertaken in the UK has shown that radiofrequency ablation of scar-related ventricular tachycardia, using robotic navigation, is safe and feasible and has resulted in 95% reduction in total implantable cardioverter defibrillator (ICD) therapy burden at six months.
The challenge of catheter ablation in congenital heart disease patients
Dominic Abrams (Division of Cardiac Electrophysiology, Boston Children's Hospital, Boston, USA) writes on the importance of arrhythmia management in congenital heart disease patients and identifies the reasons why it remains a major challenge for interventional eletrophysiology.
St Jude Medical receives FDA approval of TactiCath Quartz Contact Force Ablation Catheter
St Jude Medical has announced the US Food and Drug Administration (FDA) approval of its TactiCath Quartz irrigated ablation catheter, the company's newest technology that gives physicians a real-time, objective measure of the force that the catheter applies to a patient's heart wall during an ablation procedure.
AtriCure completes enrolment in post approval study for the Synergy Ablation System
AtriCure has announced that enrolment in the ABLATE post approval study (PAS) of its Synergy Ablation System is complete. As 3 October 2014, the ABLATE PAS enrolled 365 patients at 40 hospitals across the United States.
SMART-AF trial shows AF ablation with contact force sensing catheter is safe and effective
Results from the SMART-AF trial, recently published in the Journal of the American College of Cardiology, have shown that the ThermoCool SmartTouch contact force-sensing catheter is safe and effective for the treatment of drug-refractory symptomatic paroxysmal atrial fibrillation.
Study finds nMARQ ablation catheter fast and effective for the treatment of paroxysmal atrial...
A recent feasibility study has found irrigated multi-electrode radiofrequency ablation of atrial fibrillation using the novel 10-pole circular, open-irrigated mapping and ablation catheter nMARQ device (Biosense Webster) to be fast and effective.
St Jude Medical announces CE mark approval and first use of FlexAbility ablation catheter
The device has been designed to reduce complications associated with ablation procedures through its ability to bend and conform to the cardiac anatomy, decreasing the amount of pressure distributed to a patient's heart wall while simultaneously increasing the stability of therapy delivery.
New study of Pradaxa to explore anticoagulation in ablation of AF patients
The RE-CIRCUIT study will investigate the safety and efficacy of uninterrupted anticoagulant treatment with Pradaxa in patients with atrial fibrillation who undergo ablation. Results of the study are expected in 2016.
Population-based study confirms radiofrequency catheter ablation as safe and effective in paediatric patients
A new population-based study confirms previous study reports that radiofrequency catheter ablation is a safe method of arrhythmia treatment in children with long-term cumulative efficacy exceeding 90%, and a highly significant decrease in the procedure and fluoroscopy time during the study period.
First Latin American registry of catheter ablation of cardiac arrhythmias
Luis Aguinaga and Roberto Keegan give an overview on the design and initial results of the first Latin American catheter ablation of cardiac arrhythmias registry led by the Latin American Society of Electrophysiology and Cardiac Stimulation (SOLAECE).
Cryoballoon faster and more effective than conventional radiofrequency ablation for paroxysmal AF
A randomised controlled trial comparing three methods of pulmonary vein isolation for paroxysmal atrial fibrillation has revealed that procedures were faster and more effective with Medtronic's Arctic Front cryoballoon than wide encirclement using conventional point-by-point radiofrequency ablation. Procedures using the cryoballoon also resulted in a higher single procedure success rate.
Aggressive lifestyle management helps improve success rate after AF ablation
Researchers in Australia have found that aggressive management of cardiovascular risk factors and weight can dramatically impact the long-term success rate of freedom from atrial fibrillation following ablation.
Substrate based ablation superior than conventional ablation of stable clinical ventricular tachycardia
For stable clinical ventricular tachycardias, a substrate based ablation approach is more effective than conventional ablation preventing recurrences from any ventricular tachycardias in patients with ischaemic cardiomyopathy, according to results of the VISTA study, which is the first randomised trial performed in this area.
Advanced Cardiac Therapeutics announces new financing for TempaSure cardiac ablation catheter for treatment of...
The financing, which was led by New Enterprise Associates and supported by existing investor, NBGI Ventures, will enable the company to continue to advance its next generation TempaSure ablation catheters and related clinical development programme.
Symposium features HeartLight Endoscopic Ablation System at 80th Annual German Cardiac Society Meeting
CardioFocus has announced that leading cardiologists across Germany will gather to discuss clinical experiences with the HeartLight Endoscopic Ablation System for the treatment of atrial fibrillation on 23 April as part of the programme for the 80th Annual Meeting of the German Cardiac Society in Mannheim, Germany.
New atrial fibrillation Guideline covers novel anticoagulants, ablation
The 2014 Guideline for the Management of Patients With Atrial Fibrillation includes recommendations for an increased use of radio frequency ablation in the treatment of non-valvular atrial fibrillation, the addition of three new anticoagulants to treatment options, a diminished role in the use of aspirin, and a more comprehensive risk calculator.
Apama Medical announces claim coverage in China for electrode-based ablation balloon for the treatment...
Apama Medical announced receipt of a Chinese notice of allowance for claims covering their low profile electrode assembly that enables the attachment of flexible electrodes to an ablation balloon for energy delivery and monitoring.
Insights into BERLIN study of catheter ablation for ventricular tachycardia treatment
The BERLIN study is a prospective, multicentre study that seeks to determine the best time for catheter ablation in the treatment of patients with sustained ventricular tachycardia and coronary artery disease.
New combined mapping and ablation system for atrial fibrillation treatment undergoes testing
Hans Kottkamp, Zurich, Switzerland, presented a new device strategy that combines diagnostic and treatment capabilities for atrial fibrillation in one system, at the AF Symposium in Orlando USA (9-11 January 2014). He spoke to Cardiac Rhythm News about the combined system.
Ablation of persistent atrial fibrillation, are we there yet?
Mark Earley (London, UK) argues that despite the breathtaking progress of interventional electrophysiology in the last 10 years, ablation of persistent atrial fibrillation remains an unconquered summit.
Therapy Cool Flex Ablation Catheter and Cardiac Ablation Generator get FDA approval
The FDA has approved St Jude Medical's Therapy Cool Flex Ablation Catheter and Cardiac Ablation Generator for the treatment of atrial flutter.
HeartLight endoscopic ablation system can now be used in Spain
CardioFocus has announced that its HeartLight endoscopic ablation system is now available in Spain and Hospital Universitari i Politecnic La Fe in Valencia was the first in the country to use the technology.
Radiation exposure in supraventricular tachycardia ablation reduced with minimally fluoroscopic mapping system
Radiofrequency ablation of supraventricular tachycardia guided by the non-fluoroscopic Ensite NavX mapping system (St Jude Medical) has shown lower levels of ionising radiation exposure for the patient and for the operator compared with conventional catheter ablation, according to preliminary results from the NO-PARTY Italian trial.
What is the success rate for atrial fibrillation ablation?
Darryl Wells of the Swedish Heart and Vascular Institute, Seattle, USA, talks about how safe the ablation procedure is and how important getting patients...
Delayed enhancement-MRI detected atrial fibrosis could predict successful ablation in atrial fibrillation
Atrial fibrosis detected using delayed enhancement magnetic resonance imaging (DE-MRI) seems to be an independent predictor of procedural outcome in patients undergoing ablation of atrial fibrillation, according to results of the DECAAF (Delayed enhancement-MRI determinant of successful catheter ablation of atrial fibrillation) study
Catheter ablation may reduce stroke risk in atrial fibrillation patients
A first of its kind study has shown that patients with atrial fibrillation who undergo catheter ablation have a lower stroke risk than patients who do not undergo the procedure independent of CHADS2 score.
Idiopathic ventricular tachycardia: transcatheter ablation or antiarrhythmic drugs?
Claudio Tondo (Milan, Italy) analyses the best treatment options for different kinds of idiopathic ventricular tachycardias. He will be talking about this subject at Venice Arrhythmias (27-29 October, Venice Italy).
AlluraClarity reduces radiation in image-guided catheter ablation trial in The Netherlands
The Catharina Hospital (Eindhoven, The Netherlands) and Royal Philips has announced the results of a clinical study involving the treatment of 136 patients with complex heart rhythm disorders such as atrial fibrillation.
FDA approval for IntellaTip MiFi XP ablation catheter and 510(k) clearance of Zurpaz 8.5F...
Boston Scientific Corporation has announced it has received US Food and Drug Administration (FDA) approval of its IntellaTip MiFi XP catheter and 510(k) clearance of its Zurpaz 8.5F steerable sheath. The IntellaTip is indicated for ablation of atrial flutter.
FDA approval and first use of MediGuide enabled ablation catheters announced
St Jude Medical announced on 15 August that the US Food and Drug Administration (FDA) has approved its MediGuide enabled ablation catheters. The catheter can be tracked using 3D visualisation on previously recorded fluoroscopic images in real time.
How to prevent complications of catheter ablation for atrial fibrillation
John D Day (Murray, USA) has performed more than 3,000 catheter ablation for atrial fibrillation procedures. Based on his experience, he describes five basic principles to minimise the risk of serious complications.
The impact of radiofrequency ablation for atrial fibrillation on the gastrointestinal system
There have been a number of studies conducted to assess the efficacy and adverse effects of radiofrequency ablation of atrial fibrillation, but very little data is available on the effect of radiofrequency ablation on the upper gastrointestinal system. Dhanunjaya Lakkireddy, Kansas City, USA, reviews this subject based on the results of a new systematic approach the AF GUT study.
Ablation superior to medical therapy for patients with persistent atrial fibrillation
According to results from the SARA study, presented at a late-breaking trial session of the European Heart Rhythm Association (EHRA) Europace meeting (23-26 June, Athens, Greece), catheter ablation therapy has been shown to be superior to medical therapy for maintenance of sinus rhythm in patients with persistent atrial fibrillation.
Promising mid-term results from thoracoscopic ablation of persistent atrial fibrillation
At three-year follow-up, 80% of patients with persistent atrial fibrillation showed freedom from atrial fibrillation and were free from anti-arrhythmic drugs after thoracoscopic ablation with the Bipolar RF Ablation System (AtriCure).
Targeted ablation without pulmonary vein isolation shows 82% single procedure success rate in paroxysmal...
A late breaking trial presented at Heart Rhythm 2013 (8-11 May, Denver, USA) has demonstrated that targeted ablation of stable rotors and focal sources can eliminate paroxysmal atrial fibrillation without the need to isolate the pulmonary veins.
Boston Scientific completes first-in-human clinical trial of the IntellaTip MiFi XP Ablation Catheter for...
A company release states that this new line of ablation catheters is designed to provide physicians with high resolution, precise, multidimensional information through sophisticated micro-sensors at the tip of the catheter.
Atrial fibrillation may be reduced in sleep apnoea patients using airway pressure therapy and...
Continuous positive airway pressure may help to reduce atrial fibrillation recurrence in patients with obstructive sleep apnoea undergoing pulmonary vein isolation, a study published ahead of print in the Journal of the American College of Cardiology (JACC) has found.
EFFICAS I study yields new contact force guidelines in catheter ablation treatment of AF
Results from the EFFICAS I, a prospective multicentre study sponsored by Endosense, have led to the development of guidelines for target and minimum contact force, as well as minimum force time integral, during the catheter ablation treatment of paroxysmal atrial fibrillation.
Stereotaxis receives Japanese regulatory approval of Niobe technology for cardiac ablations
Approval by the Japanese Pharmaceuticals and Medical Devices Agency follows a successful three-year clinical trial of the Niobe remote magnetic technology for cardiac ablations at the Tokyo Women's Medical University.
Endosense closes an additional US$4.3 million to finance ablation technology
The added finances will further support Endosense's programme to get access to the US market with its TactiCath Quartz contact-force sensing ablation catheter and to reinforce sales in Europe.
HeartLight Endoscopic Ablation System to be highlighted at Frankfurt Atrial Fibrillation Academy 2013
The Annual Frankfurt Atrial Fibrillation Academy Symposium will highlight the latest innovations and research in atrial fibrillation therapy.
Newer approaches in ablation for ventricular fibrillation
"Ventricular fibrillation was generally viewed as a non-ablatable rhythm disturbance. However, several advances over the last decade have enabled electrophysiologists to successfully address this arrhythmia with ablation techniques," writes Samuel J Asirvatham, Mayo Clinic, Rochester, USA.
Understanding ablation of ventricular tachycardias
Richard Hongo, cardiac electrophysiologist, California Pacific Medical Center, San Francisco, USA, explains how ablation of ventricular tachycardias works.
https://youtu.be/Y-YzXbfcAas
First US case performed with Endosense’s Tacticath Quartz contact-force sensing ablation catheter
The first US case was performed on 31 January 2013 as part of an amended protocol of the company's TOCCASTAR investigational device exemption clinical study of the TactiCath called the TOCCASTAR Supplemental Clinical Study.
Faster lower pacing rate after atrioventricular node ablation may help to decrease sudden death...
Faster lower pacing rate immediately after atrioventricular node ablation with a gradual decrease helps to improve clinical outcome and may reduce the risk of sudden death in patients with atrial fibrillation, Ru-Xing Wang and other reported in Heart Rhythm ahead of print.
FDA clears EPi-Sense cardiac ablation device with embedded sensors
This next generation of technology includes sensors along the ablation device which provide real-time feedback to physicians conducting cardiac ablation procedures.
First patient treated in trial to evaluate the safety and performance of the Blazer...
The ZERO AF study will include up to 33 sites in the USA, Europe and Asia-Pacific, and the results will be used to support a FDA submission for a paroxysmal AF indication.
Over 1,000 atrial fibrillation cases performed with the HeartLight ablation system
CardioFocus has announced that more than 1,000 clinical cases have been performed worldwide using its HeartLight Endoscopic Ablation System technology for the treatment of atrial fibrillation.
Minimally invasive hybrid ablation is safe and effective for treatment for atrial fibrillation patients
One year after treatment completion, 80% of patients in normal sinus rhythm without administration of drugs, study says.
Successful catheter ablation may reduce total mortality
A study recently published in EP Europace has shown that successful catheter ablation of atrial fibrillation may reduce the risk of total mortality, cardiovascular mortality and total vascular events in patients with an increased risk of stroke.
Endosense secures US$40.3 million series c financing to advance cardiac arrhythmias treatment with catheter...
Proceeds will be used to support commercialisation of the recently European introduction of the third-generation TactiCath Quartz force-sensing catheter; development of next generation products; completion of the TOCCASTAR investigational device exemption clinical study follow-up and FDA approval submission for the TactiCath.
Early data for over-the-wire mesh ablation system is “encouraging”
At Europe AF (18-19 November, London, UK), Dirk Mueller, Bad Bevensen, Germany said that the initial results of the GENESIS study validated the usability of the Over-the-Wire Mesh Ablation System (OTW MAS, Encompass, Bard Electrophysiology) for paroxysmal atrial fibrillation.
High-dose visually guided laser ablation superior to low-dose ablation in treatment of patients with...
New data have shown that acute pulmonary vein isolation was achieved after a single visually guided circular lesion set in 89% and 69% of patients in the high and low-dose groups, respectively.
HeartLight Ablation System receives unique classification code in Germany for the treatment of atrial...
Use of the new code allows the German Institute of Medical Documentation and Information to track the number of atrial fibrillation patients being treated with laser ablation guided by endovascular endoscopy and provides the initial step to receiving a specific diagnosis-related group code for the procedure.
Gold-tip ablation catheters create lesions 33% faster than platinum-iridium-tip catheters
Results from the GOLDEN TIME study have shown that gold-tip radiofrequency ablation catheters enable faster, more efficient ablation procedures than platinum-iridium-tip catheters.
nContact receives US patents for epicardial ablation technology for cardiac arrhythmias
The four patents issued cover essential components of the multidisciplinary epicardial-endocardial approach pioneered by nContact for the treatment of cardiac arrhythmias.
Catheter ablation can be performed safely while a patient is on uninterrupted warfarin
Stephen Page and Richard Schilling, St Bartholomew's Hospital, UK, explain why catheter ablation can be performed safely in most patients with uninterrupted warfarin.
Estech launches the Cobra Fusion system for cardiac ablation
Cobra Fusion incorporates proprietary Versapolar technology which delivers both bipolar and monopolar radiofrequency (RF) energy to the targeted cardiac tissue, enabling transmural lesion formation in thin and thick cardiac tissue.
HeartLight Endoscopic Ablation System now available in Australia
Monash Medical Centre in Melbourne is the first cardiology centre in the country to offer this catheter ablation treatment.
TactiCath Quartz Force-Sensing Ablation Catheter gets CE mark approval
Endosense and Biotronik have announced that Endosense's TactiCath Quartz force-sensing ablation catheter has been CE mark approved in Europe.
Data presented at HRS 2012 suggest Convergent Procedure ablation may restore persistent atrial fibrillation...
nContact has announced that new long-term physician data demonstrated promising clinical outcomes for the multidisciplinary Convergent Procedure in the treatment of persistent atrial fibrillation (AF), with over 80% of patients remaining in sinus rhythm at a minimum of 12 months follow-up.
Symposium on epicardial approach to posterior cardiac ablation convened at Heart Rhythm 2012
Electrophysiology thought leaders gathered to discuss the significance of posterior ablation in the treatment of arrhythmias, with presentations highlighting the importance of isolating the posterior left atrium with an adjunctive epicardial treatment.
“The future of AF ablation catheter technologies”: A new report reveals the potential of...
Design and technology consultancy Cambridge Design Partnership has announced that it has completed a research project to identify the future of medical technology to treat atrial fibrillation.
Radiofrequency catheter ablation is safe and effective in the octogenarian patient with atrial fibrillation
A study published in the Journal of Cardiovascular Electrophysiology shows that catheter ablation of octogenarians with atrial fibrillation is as safe and effective as catheter ablation of atrial fibrillation in younger patients
Catheter ablation of ventricular tachycardia in patients with ARVD/C significantly reduces the burden of...
A new study, published in Circulation: Arrhythmia and Electrophysiology, indicates that catheter ablation of ventricular tachycardia is an important treatment option in patients with ARVD/C, despite a high rate of ventricular tachycardia recurrence, because it reduces the burden of the arrhythmia
HeartLight Endoscopic Ablation System now available in the Netherlands
Physicians at Isala Klinieken in Zwolle, Netherlands, were the first in the country to incorporate CardioFocus' visually guided ablation technology.
New study to investigate the role of early radiofrequency ablation in delaying progression of...
ATTEST, a prospective, multicentre, randomised, controlled study will compare pulmonary vein isolation (using Biosense Webster's ThermoCool catheters and the company's Carto 3 or Carto XP mapping systems) with drug therapy (rate or rhythm control) in patients with paroxysmal atrial fibrillation.
Preclinical study examines percutaneous approach to epicardial ablation of ventricular tachycardia
A new preclinical study shows that a unique minimally invasive percutaneous approach to accessing the heart may enable electrophysiologists to perform epicardial ablation for ventricular tachycardia.
Two poster presentations at Boston AF highlight positive results of a multidisciplinary ablation procedure
At Boston AF, two poster presentations showed that a multidisciplinary procedure that uses both epicardial and endocardial ablation (convergent procedure) is associated with high single procedure efficacy in a patient population dominated by persistent atrial fibrillation.
New consensus document for atrial fibrillation ablation previewed at Boston AF
Hugh Calkins, Maryland, USA gave a sneak preview of the forthcoming 2012 document on catheter ablation for atrial fibrillation. At Boston AF he said, the new document is not just a "brief update" of the previous HRS/EHRA/ECAS document, which was published in 2007, but a "comprehensive, state-of-the-art review of the field of catheter and surgical ablation for atrial fibrillation."
Single atrial fibrillation ablation procedure achieves high pulmonary vein isolation rates, study shows
Researchers in Germany achieve 98% acute pulmonary vein isolation, with 77% of patients in sinus rhythm at approximately nine months follow-up.
Revised ablation guidelines previewed at Boston AF
Preview of the revised HRS/EHRA/ECAS consensus document on catheter ablation for atrial fibrillation at Boston AF (12-14 January 2012, Boston, USA) reveals new recommendation to use the CHADS2-VASc score
FDA approves AtriCure’s Synergy Ablation system for atrial fibrillation treatment
AtriCure's Synergy Ablation system has been approved for the treatment of patients with persistent and long-standing persistent atrial fibrillation during open-heart concomitant coronary artery bypass grafting and/or valve replacement or repair procedures.
Husam Balkhy performs robotic RF ablation with the Cobra Adhere XL
Husam Balkhy, director Center for Minimally Invasive Cardiac and Robotic Surgery, The Wisconsin Heart Hospital, USA, performs a totally endoscopic robotic RF ablation procedure...
Estech starts patient enrolment in HISTORIC-AF European ablation study
The HISTORIC-AF staged hybrid ablation study will enrol persistent and long-standing persistent atrial fibrillation (AF) patients at ten centres in Italy, Germany, the United Kingdom, France, and Poland.
Surgical ablation is more effective but has more procedure-related adverse events than catheter ablation
A trial, simultaneously published online in Circulation and presented at the annual scientific sessions of the American Heart Association (AHA; 12-16 November, Orlando, Florida) has found that minimally invasive surgical ablation is more effective than catheter ablation but is also associated with more procedure-related adverse events
Measuring both left atrial size and the amount of left atrial fibrosis may improve...
A study, published in Heart, indicates that the combined assessment of left atrial size and the amount of left atrial fibrosis may improve the identification of patients who have a high likelihood of successful ablation.
FDA advisory panel votes against Medtronic Phased RF Ablation System for atrial fibrillation
The majority of the panel does not believe there is reasonable assurance of the safety of Medtronic's ablation system, and that the clinical benefits of the technology do not outweigh the potential risks based on the TTOP-AF clinical trial data.
Surgical ablation system for atrial fibrillation receives recommendation from FDA expert advisors
FDA's Circulatory System Devices Panel recommended AtriCure's Synergy ablation system for the treatment of atrial fibrillation during open-heart concomitant surgical procedures.
Ablation therapy in atrial fibrillation patients shows to be effective but risky
The TTOP-AF trial results showed a 90% reduction in atrial fibrillation or atrial flutter burden in 55.8% of ablation patients; however the results did not meet the pre"defined performance safety goal of 16%.
Gender does not affect periprocedural complications or long-term results of catheter ablation
Despite influencing the epidemiology, pathology, and clinical presentation of cardiac arrhythmias, gender does not appear to affect periprocedural complications and outcomes of catheter ablation, according to a study presented by Sonia Ammar, Munich, Germany at EHRA-Europace in Madrid, Spain.
Remote magnetic navigation and ablation shows promise in patients with scar-related ventricular tachycardia
"The main advantage of the Niobe Remote Magnetic Navigation System (Stereotaxis), is the precise mapping and identification of the critical diseased portions of the heart that allows physicians to perform ablation in a more effective way," said Petr Neuzil, lead investigator of the STOP-VT study presented at the ESC Congress in Paris.
HeartLight endoscopic ablation system available in the UK
HeartLight EAS (CardioFocus) is used for the treatment of atrial fibrillation. It features an illuminating endoscope to provide physicians with direct visualisation within a beating heart, in real time and without radiation.
EPi-Sense epicardial ablation system gets CE mark
The EPi-Sense (nContact) features first-of-its kind epicardial sensing electrodes designed to allow both electrophysiologists and cardiothoracic surgeons to map and navigate the epicardium and locate areas for linear epicardial ablation.
First atrial flutter patient treated with novel MRI ablation catheter
The development of this novel catheter, specially designed to be used with magnetic resonance imaging, could represent a significant new opportunity for improved therapy of complex cardiac arrhythmias.
Carlo Pappone performs AF ablation with Stereotaxis magnetic navigation system
Carlo Pappone, The San Raffaele Hospital, Milan, Italy, performs atrial fibrillation ablation with Stereotaxis remote magnetic navigation system and CARTO RMT non fluoroscopic mapping...
Endosense and GE Healthcare sign joint development agreement to improve catheter ablation procedures
The agreement will integrate the contact-force data provided by Endosense into GE's CardioLab electrophysiology recording and Innova imaging platforms.
New AF ablation technologies: useful tools or just expensive toys?
Fiorenzo Gaita, Università degli Studi di Torino, Turin, Italy, spoke to Cardiac Rhythm news about the real impact of fluoroscopy, intracardiac echocardiography and virtual 3D electro-anatomic mapping in atrial fibrillation ablation.
New stretchable device promises to make ablation simpler
The new tool has all necessary medical devices printed on a standard balloon catheter: a device for eliminating damaged tissue using heat, temperature and pressure sensors, a light-emitting diode (LED) and an electrocardiogram sensor.
St. Luke’s Episcopal Hospital is among the first in the USA to offer cryoablation...
J Alberto Lopez, a physician affiliated with Texas Heart Institute at St. Luke's Episcopal Hospital, is the first in Houston and among the first in the nation to treat patients with paroxysmal atrial fibrillation with cryoablation technology.
Mount Sinai performs first US cardiac ablation using contact force-sensing catheter to treat atrial...
The first catheter ablation procedure was performed at the end of February by Vivek Y. Reddy, director of the Cardiac Arrhythmia Service at Mount Sinai Heart and colleagues.
The European cardiac rhythm management, electrophysiology and ablation market valued at over €2.8 billion...
These markets could reach over €4.4 billion by 2017, according to a report published by iData Research.
Pulmonary vein isolation with cryoballoon comparable to radio frequency ablation
The Arctic Front Cryoballoon from Medtronic is safe with very low incidence of pulmonary vein stenosis and no cryo-related left atrial perforation and low thrombogenic risk. Results were presented by Wyn Davies, London, UK, at the annual Europe AF meeting in London, UK.
Endosense and Siemens Healthcare work together in development project to improve electrophysiology ablation procedures
The main goal of the shared development project is to achieve an improved visualisation of catheter-tip-to-tissue contact force within a three-dimensional anatomic heart model during catheter ablation procedures.
First clinical ablation cases in the EU using the Thermocool Smarttouch contact force sensing...
The CE-marked Thermocool Smarttouch catheter provides an important new parameter for the mapping and ablation of complex cardiac arrhythmias, such as atrial fibrillation.
TOCCASTAR IDE study of TactiCath force-sensing ablation catheter (Endosense) is launched
TOCCASTAR will explore a new catheter ablation treatment option for patients who have symptomatic paroxysmal atrial fibrillation and who are resistant or intolerant to at least one Class I-IV anti-arrhythmic drug.
Repeat ablation procedures provide “acceptable” long-term relief for AF patients
Five-year follow-up results from a study of catheter ablation for atrial fibrillation shows long-term success increases when outcomes are measured after the last ablation procedure.
FDA approves cryoballoon ablation treatment for paroxysmal AF
The Arctic Front Cardiac CryoAblation Catheter system is the first and only Cryoballoon in the United States indicated for the treatment of drug refractory paroxysmal atrial fibrillation.
Symptoms and quality of life improved with catheter ablation in AF patients
Patients who were treated with catheter ablation reported fewer symptoms and improved quality of life than patients treated with anti-arrhythmia drugs at one year.
Worldwide survey shows ablation works without drugs in most cases
Riccardo Cappato, Centre of Clinical Arrhythmia and Electrophysiology, Policlinico San Donato, Milan, makes his case following the second global survey on catheter ablation.
STOP-AF shows cryoablation prevents atrial fibrillation better than drugs
Professor Douglas Packer presents the results of two clinical trials conducted using the cryoablation technique.
CABANA pilot shows ablation more effective in preventing AF recurrence
Professor Douglas Packer presents the results of the pilot study at the American College of Cardiology Scientific Sessions.
Promising results for cryoablation presented at ACC congress
Safety and effectiveness trial evaluated the Medtronic Arctic Front Cardiac CryoAblation Catheter System for the treatment of paroxysmal atrial fibrillation.
New study uncovers gender disparity in ablation treatment and outcomes for AF
Study published in HeartRhythm Journal shows female patients undergo catheter ablation less often and experience more complications than males
More centres perform ablation for persistent and permanent AF
New observations from the Second Worldwide Survey on AF Ablation showed that more procedures are being offered every year.
Trials beginning this year will compare AF ablation devices
An overview of clinical trials on AF ablation devices seeking FDA approval was presented by Hugh Calkins, Johns Hopkins Hospital, Baltimore, USA, at the Boston AF Symposium.
New Lynx robotic irrigated ablation catheter is presented at Venice Arrhythmias
Hansen Medical showcased the small, flexible irrigated ablation catheter for the first time. CE mark is expected in the first half of 2010.
Paroxysmal and non-paroxysmal AF patients benefit from repeat catheter ablation
Isolation of the pulmonary vein antrum and the superior vena cava using intracardiac echocardiography and circular mapping can achieve encouraging cure rates.
Cost-effectiveness of atrial fibrillation catheter ablation
Panos E Vardas, president of the European Heart Rhythm Association, analyses the trend on expanding the existing indications and usage of ablation.
CardioFocus receives CE mark for AF ablation catheter
The device incorporates a micro-endoscope and light energy fibres to give physicians the capacity to see within the heart and visually direct the application of energy through a catheter.
Mixed evidence on use of radiofrequency catheter ablation for AF
Report funded by the US Agency for Healthcare Research and Quality calls for more research on the effect of catheter ablation on quality of life.
Mayo Clinic receives US$48 million in grants to study catheter ablation for AF
The CABANA trial is designed to determine whether catheter ablation is more effective than drug therapy for the treatment of atrial fibrillation.
Expert consensus statement on the catheter ablation of ventricular arrhythmias is released
State-of-the-art review of catheter ablation of VT by an international panel of experts was released during the Heart Rhythm Society's 30th Annual Scientific Sessions.
Endosense receives CE mark for TactiCath force-sensing ablation catheter
Approval was granted based on select data submitted from the TOCCATA clinical study, which was performed by 17 experienced investigators at eight European centres.
One in 1,000 risk of death from catheter ablation for AF
Analysis of data from 162 centres worldwide between 1995 and 2006 showed that tamponade caused the highest number of fatalities, followed by stroke and atrioesophageal fistula.
Advances in ablation of long-standing persistent AF
Matthew Wright, Hopital Cardiologique du Haut-Levaque, Bordeaux-Pessac, France talks about techniques and developments in catheter ablation for persistent AF.
Angiography could avoid coronary lesions after ablation in youngsters with a posteroseptal pathway
Study assessed the incidence of coronary artery injury early after catheter ablation for supraventricular tachycardias in children.
Increasing use of ablation to treat atrial fibrillation
American report says number of catheter ablation procedures for treating atrial fibrillation will fuel revenues in the electrophysiology ablation catheter market over the next five years.
British investigators demonstrate safety of AF ablation in the elderly
Investigators from The Heart Hospital, University College London, have demonstrated that atrial fibrillation ablation in older patients can be achieved safely with similar complication risks.
Cryoablation appears effective for paroxysmal but not persistent AF
The novel cryoballoon device (Arctic Front, Cryocath) appears safe and effective for patients with paroxysmal atrial fibrillation (AF), but not for those with persistent AF, according to German researchers.
Robotic electrophysiology programme opens in south eastern USA
Stereotaxis has announced the opening of a new robotic electrophysiology programme at Broward Health Medical Center in Fort Lauderdale, USA. Broward Health is among...
First patients treated in Kardium PULSAR IDE study of Globe pulsed field system
Kardium, a private medical device company that has developed the Globe pulsed field (PF) system for the treatment of atrial fibrillation (AF) using pulsed...
Analysis of NIS database shows racial disparities in atrial fibrillation outcomes in heart failure
Using data from a large and “nationally representative” sample of the US population, a recent study is the first—the authors posit—to demonstrate racial differences...
ACC 2023: Pulsed AF trial yields “promising” safety and efficacy results for PFA system
Results of the Pulsed AF Pivotal trial, investigating pulsed field ablation (PFA) treatment in patients with paroxysmal and persistent atrial fibrillation (AF), have been...
Early rhythm control aids recurrent stroke prevention in patients with AF
Early rhythm control one year after atrial fibrillation (AF) diagnosis has been found to be beneficial in preventing recurrent stroke in patients with incident...
ACQFORCE FLUTTER trial meets primary safety and efficacy endpoints
Acutus Medical has announced results from the AcQForce Flutter study, evaluating use of the AcQBlate Force sensing ablation catheter and system in the treatment...
AF Symposium hears late-breaking data from RFA and PFA trials
Biosense Webster has announced an update and late-breaking data from trials across radiofrequency ablation (RFA) and pulsed field ablation (PFA) at the 2023 AF...
RA Medical Systems finalises merger with Catheter Precision
Ra Medical Systems announces the completion of its previously-announced stock-for-stock merger transaction with Catheter Precision, a company focused on the cardiac electrophysiology market.
MedTech veteran...
Volta Medical secures multimillion Euro series B funding round
Volta Medical has announced €36 million in new series B funding, bringing the total capital raised to over €70 million.
The company is developing artificial...
Measurement of left atrial mechanical function found to improve stroke prediction
A cohort study of more than 4,500 persons without a history of atrial fibrillation (AF) or stroke has found that measuring left atrial mechanical...
Field Medical and CardioNXT to collaborate on 3D integrated PFA therapy
Field Medical and CardioNXT have announced a strategic collaboration to provide the first-of-its-kind focal pulsed field ablation (PFA) therapy integrated with 3D mapping &...
EU Commission to propose delay to MDR implementation
Europe’s health commissioner, Stella Kyriakides, has announced that proposals to extend the transition period for the implementation of the European Union’s (EU) Medical Device...
ESC warns of cardiac device shortage due to implementation of MDR regulations in Europe
The European Society of Cardiology (ESC) has urged European Union (EU) health ministers to act to prevent a “shortfall of essential medical devices for...
Study reveals low reconnection rate with large antral lesion at PW after pentaspline PFA...
A first-of-its-kind analysis on electrophysiological findings in patients with recurrent atrial tachyarrhythmia (ATa) following pulmonary vein isolation (PVI) using the novel pentaspline pulsed-field ablation...
Study of Signal Complexity algorithm for AF detection launched
CathVision has announced the investigation of the Signal Complexity algorithm designed to visualise and quantify atrial fibrillation (AF) complexity parameters in patients with persistent...
Adagio Medical announces patient enrolment in PARALELL trial
Adagio Medical has announced its first pulsed field cryoablation (PFCA) procedure performed using the Adagio CryoPulse catheter system as part of the PARALELL (Pulsed...
Cardiac mapping system “reduces procedural duration and fluoroscopy use”
Vektor Medical has announced study results that demonstrate a reduction in total procedural duration, fluoroscopy use, and cost after implementation of vMap, its cardiac...
Two decades of development in AF treatment and education
This year marked the 20th edition of the Atrial Fibrillation Symposium (AFIB2022; 24–25 May, Copenhagen, Denmark) which, over its lifetime, has evolved to become...
Vascade vascular and venous closure devices gain CE mark
Haemonetics Corporation has received CE mark certification for its Vascade vascular closure and Vascade MVP venous vascular closure systems.
The CE marking will allow...
IMPACT II trial expands to USA following FDA exemption approval
The US Food and Drug Administration (FDA) has granted an investigational device exemption (IDE) to Attune Medical to evaluate the company’s ensoETM in the...
Findings of vMAP study detail accuracy of cardiac mapping technology
Vektor Medical has announced the publication of a peer-reviewed manuscript of the clinical data from a study evaluating the accuracy of its vMap technology...
Biosense Webster launches Octaray mapping catheter
Biosense Webster has announced the release of the Octaray mapping catheter, developed for the mapping of cardiac arrhythmias including atrial fibrillation (AF). The catheter...
ESC 2022: Findings of CAPLA trial “do not support inclusion of posterior wall isolation”...
The addition of posterior wall isolation (PWI) does not improve arrhythmia outcomes compared with pulmonary vein isolation (PVI) alone in patients undergoing first time...
Study looks at efficacy of AI-based EGM analysis tool
Volta Medical has announced that peer-reviewed results from the company’s Ev-AIFib proof of concept study with its VX1 decision support software has been published...
Medtronic adds cardiac mapping platform through Affera acquisition
Medtronic has announced that it has completed the acquisition of Affera. The acquisition will expand Medtronic’s cardiac ablation portfolio to include its first cardiac...
Centauri pulsed electric field system gains CE mark approval
Galaxy Medical has announced that it received the CE mark for its Centauri pulsed electric field (PEF) system and launched its commercial programme.
The approval...
Recent AF diagnosis and multiple comorbidities warrants early rhythm control strategy
Patients with recently diagnosed atrial fibrillation (AF) with a high burden of comorbidities should be considered for early rhythm control to reduce cardiovascular outcomes,...
AHA scientific statement offers insight into sleep-disordered breathing and its link to arrhythmia
A new scientific statement from the American Heart Association (AHA) provides guidance about sleep-disordered breathing and its association with the development of cardiac arrhythmia.
Published...
CathVision secures US$7.2 million in funding to advance EP recording technology
CathVision has secured US$7.2 million in funding from existing investors to help advance commercial operations driving adoption of the ECGenius system, the company's EP...
OSYPKA AG gains CE mark for class III pacing electrode
OSYPKA AG, a medical device company based in Rheinfelden, Germany, has received the CE mark under the European Union’s Medical Device Regulation (MDR) for...
Cryocure-2 study reports 85% freedom from AF at one year
Adagio Medical has announced the publication of the results of its Cryocure-2 ultra-low temperature cryoablation (ULTC) study in patients with atrial fibrillation (AF) in...
Analysis sets out generalisability of EAST-AFNET 4 trial findings
Around 80% of patients diagnosed with atrial fibrillation (AF) in the UK population are eligible for early rhythm control, an analysis of the EAST-AFNET...
Stereotaxis submits CE mark application for MAGiC catheter
Stereotaxis has announced the CE mark submission for its MAGiC catheter, a robotically navigated magnetic interventional ablation catheter for minimally invasive cardiac ablation procedures.
MAGiC...
Thromboembolic cerebral events ‘rare’ in patients undergoing PFA
In patients treated with pulsed field ablation (PFA) for symptomatic paroxysmal atrial fibrillation (AF), the incidence of asymptomatic thromboembolic cerebral events or lesions detected...
First patient treated in HEAL-IST clinical trial
AtriCure has announced that the first patient has been treated in the HEAL-IST trial, evaluating the safety and effectiveness of AtriCure’s Isolator Synergy Clamp...
First patients enrolled in IMPACT II study
Attune Medical has announced that the first patients have been enrolled in the IMPACT II— Improving Oesophageal Protection During Catheter Ablation for Atrial Fibrillation—study,...
FDA approval granted for inHEART 3D imaging analysis software
inHEART has received US Food and Drug Administration (FDA) 510(k) clearance for its inHEART Models software suite that enables 3D visualisation and analysis of...
FDA clears ECGenius high-fidelity, low-noise electrophysiology recording technology
CathVision has announced US Food and Drug Administration (FDA) 510(k) clearance of the ECGenius electrophysiology recording system. ECGenius acquires high-fidelity, low-noise, cardiac electrograms to...
CathVision completes enrolment in ECGenius study
CathVision has completed patient enrolment in the CathVision ECGenius System clinical evaluation study at the University of Vermont Medical Center (Burlington, USA). The study...
EHRA 2022: Overweight patients at greater risk of AF recurrence
Overweight patients with atrial fibrillation (AF) are more likely to experience a return of the heart rhythm disorder after a corrective procedure than those...
SafeCross transseptal balloon gets first commercial use
East End Medical has announced the first commercial use of its SafeCross transseptal radiofrequency (RF) puncture and steerable balloon introducer system. The system is...
Updated cardiac mapping system among Philips’ EHRA 2022 offering
The launch of the latest KODEX-EPD cardiac mapping and navigation system is among the features Royal Philips will showcase at the 2022 European Heart...
Poland establishes its first robotic electrophysiology unit
Stereotaxis has announced that Poland’s National Institute of Cardiology in Warsaw has established the first robotic electrophysiology programme in the country with Stereotaxis’ Genesis...
AF Symposium 2022: Lower pulmonary vein to left atrium volume ratio predicts AF recurrence
Pulmonary vein-left atrial (PV/LA) volume ratio is a significantly better predictor power for atrial fibrillation (AF) recurrence than LA dimension in patients with normal...
Siemens introduces “integrated” cath lab imaging system, Artis icono biplane
Siemens Healthineers has announced the launch of Artis icono biplane—an angiography system with detectors optimised in size for integrated use in the cath lab.
The...
Boston Scientific closes acquisition of Baylis Medical Company
Boston Scientific has announced the close of its acquisition of Baylis Medical Company, a company that offers advanced transseptal access solutions as well as...
UCSD is the first hospital to offer vMap arrhythmia mapping software
Vektor Medical has announced that the University of California, San Diego Health (UCSD, San Diego, USA) is the first hospital system to offer the...
AtriAN Medical present results of Neural AF trial at AF Symposium 2022
According to a press release, AtriAN Medicals clinical data from the Neural atrial fibrillation (AF) study was presented by Vivek Reddy (Mount Sinai Hospital,...
EnSite X EP cardiac mapping platform gains US FDA approval
Abbott has received clearance from the US Food and Drug Administration (FDA) for the EnSite X EP system with EnSite Omnipolar Technology (OT), a...
Medtronic to acquire Affera
Medtronic has announced that it has entered into an agreement to acquire medical technology company Affera.
Affera designs and manufactures cardiac mapping and navigation systems...
First patient treated in SPHERE PerAF trial
Affera has announced that the first patient was treated in the recently approved SPHERE PerAF trial, a US Food and Drug Administration (FDA) Investigational...
First-in-man procedures performed with Globe PFA system
Kardium has announced the completion of successful first-in-human (FIH) procedures with the Globe pulsed field system.
Vivek Reddy of Mount Sinai Hospital (New York, USA)...
SyMap Medical closes US$100 million financing round
SyMap Medical has announced the completion of a financing round which will be used to accelerate global clinical trials for the company’s renal mapping...
AcQForce PFA-CE study begins for focal PFA therapy to treat atrial fibrillation
Acutus Medical has announced the initiation of AcQForce PFA-CE, a clinical study that will evaluate the safety and performance of the company’s focal force...
Vektor Medical’s vMap receives FDA 510(k) clearance
Vektor Medical has announced US Food and Drug Administration (FDA) 510(k) clearance for its novel computational electrocardiogram (ECG) mapping system, vMap.
vMap is designed to...
First patients enrolled in PVISION study of PVI analyser
CathVision has announced the first patient enrolments in the PVISION multicentre clinical study, investigating the automated assessment of pulmonary vein isolation (PVI) using the...
Robotics in the EP lab: Pointing the way to the future
Benjamin D’Souza, assistant professor of Medicine at the University of Pennsylvania, cardiac electrophysiologist at Penn Presbyterian Medical Center, Philadelphia, USA, discusses the recent developments...
First patients enrolled in SPACE-AF study
Galaxy Medical announced today the initiation of the SPACE-AF study with enrolment of the first two patients at Southlake Regional Health Centre in Newmarket,...
Stereotaxis and Microport EP announce Chinese market partnership
Stereotaxis and Shanghai Microport EP Medtech have announced a broad collaboration to advance technology innovation and commercial adoption of robotics in electrophysiology in China.
The...
ESC 2021: Initial data from inspIRE clinical trial released
Biosense Webster, part of the Johnson & Johnson Medical Devices Companies, has announced the presentation of data from the inspIRE clinical trial at the...
ESC 2021: ACTIVE-AF finds benefits for exercise programme in AF patients
A six-month exercise programme helps maintain normal heart rhythm and reduces the severity of symptoms in patients with atrial fibrillation (AF), according to late-breaking...
Acutus receives FDA and CE mark approvals for AcQMap 8
Acutus Medical has received US Food and Drug Administration (FDA) and CE mark clearance for its suite of software upgrades known collectively as AcQMap...
HRS 2021: Early rhythm control benefits AF patients with heart failure
Rhythm control therapy offers a clinical benefit when initiated within one year of a diagnosis of atrial fibrillation (AF) in patients with signs or...
HRS 2021: DOACs reduce risk of stroke in patients undergoing left ventricular RFA
Use of direct oral anticoagulants (DOACs) in patients undergoing ventricular tachycardia radio frequency ablation (RFA) is associated with a reduced risk of transient ischaemic...
AliveCor and Acutus partner for post-market study
AliveCor and Acutus Medical will collaborate to assess the integration of data collection tools across the cardiology continuum of care, which the companies say...
Affera’s SpherePVI gets first-in-human use
Affera has announced the first-in-human use of its circumferential pulmonary vein isolation (PVI) pulsed field ablation (PFA) catheter, SpherePVI.
The work was conducted as part...
Research highlights AF risk factors for HCM patients
The authors of research published in JACC: Clinical Electrophysiology claim that their findings will help physicians to identify, treat and prevent atrial fibrillation (AF)...
FDA approval for SafeCross transseptal RF system
East End Medical has announced it has received US Food and Drug Administration (FDA) clearance for the company's SafeCross transseptal radiofrequency (RF) puncture &...
Boston acquires remaining shares of Farapulse
Boston Scientific has exercised its option to acquire the remaining shares of Farapulse. The acquisition will complement the existing Boston Scientific electrophysiology portfolio to...
CardioFocus receives Japanese approval for HeartLight X3
CardioFocus has announced that the Japanese Ministry of Health, Labor and Welfare (MHLW) has approved the company's HeartLight X3 System for marketing in Japan....
Abbott initiates trial focusing on twin AF and heart failure treatments
Abbott has announced a new trial focused on improving the treatment for people simultaneously battling both atrial fibrillation (AF) and heart failure.
The TAP-CHF trial...
AtriCure’s EPi-Sense system approved by US FDA for treatment of long-standing persistent AF
AtriCure has announced US Food and Drug Administration (FDA) approval of the EPi-Sense system to treat patients diagnosed with long-standing persistent atrial fibrillation (AF).
The...
Putting the patient at the centre of the AF treatment strategy
This article was sponsored by Biosense Webster
Putting the patient at the centre of the discussion is vital to setting the right strategy for the...
AcQCross transseptal crossing devices gain US FDA clearance
Acutus Medical has announced US Food and Drug Administration (FDA) clearance of the AcQCross family of universal transseptal crossing devices. The transseptal puncture system...
MultiPulse therapy “shows promise” in the treatment of AF
Cardialen has announced the publication of a first-in-human study in the Journal of the American College of Cardiology: Clinical Electrophysiology investigating its low-voltage MultiPulse...
US enrolment in AcQForce Flutter IDE clinical trial commences
Acutus Medical has announced initial US enrolment in the company’s AcQForce Flutter Investigational Device Exemption (IDE) clinical trial. The trial is expected to enrol...
Looking ahead to AFIB2021
Far from being the first event in the electrophysiology calendar now to make the switch to a digital-only format, the 2021 edition of the...
First procedures performed in pivotal trial to evaluate PulseSelect PFA system
Medtronic has announced the first procedures in the investigational device exemption (IDE) pivotal trial to evaluate the PulseSelect pulsed field ablation (PFA) system, a...
AF burden at six months predictive of hard clinical outcomes in heart failure
Atrial fibrillation (AF) burden at six months after catheter ablation is predictive of all-cause mortality and heart failure hospitalisation, in AF patients with heart...
HeartLight X3 pivotal study meets safety and efficacy endpoints
CardioFocus has announced that results from the HeartLight X3 Pivotal Study have been published online in the journal Circulation: Arrhythmia and Electrophysiology (CircEP), showing...
MedLumics closes on financing round and makes board appointment
MedLumics has announced that it has closed an €18 million (US$21.7 million) financing round and has appointed Rich Ferrari as Chairman of the Board...
AF Symposium 2021: Studies explore lattice-tip catheter strategies for AF
Findings of two studies investigating the use of a lattice-tip catheter for the treatment of atrial fibrillation (AF) were presented during a late-breaking trial...
AF Symposium 2021: Live case from ECLIPSE-AF study to feature
Galaxy Medical, a developer of pulsed electric field (PEF) technology for the treatment of cardiac arrhythmias, has announced that the proprietary Centauri system will...
AF Symposium 2021: Early results of CathVision Cube to be announced
CathVision ApS has announced that its novel cardiac electrophysiology system and artificial intelligence platform to guide ablation therapy for heart rhythm disorders, will be...
AF Symposium 2021: Two cases highlight Acutus’ mapping technology
Acutus Medical has announced a number presentations relating to its mapping and ablation procedures during 26th Annual International AF Symposium (29–31 January, virtual). The...
RHYTHM AI announces latest publication of data backing its STAR Mapping system
RHYTHM AI has announced publication of a clinical outcome study for its STAR (Stochastic Trajectory Analysis of Ranked signals) Mapping system, which is designed...
Remote technology in cardiac care is “here to stay”
Robert Klempfner, is director of the Israeli Center for Cardiovascular Research, and director of the Cardiovascular Prevention and the Cardiac Rehabilitation Institutes at Sheba...
Wearables offer “great potential” in AF screening but physicians cautious over mass use
Consumer wearables offer a great potential for the screening of atrial fibrillation (AF), however two thirds of healthcare professionals admit to concerns over mass...
Volta Medical secures €23 million in financing round
Volta Medical, a French health technology startup working on artificial intelligence (AI) algorithms to treat cardiac arrythmias, has announced that it has successfully raised...
High power CLOSE-guided PVI “increases procedural efficiency”
Results of a prospective randomised evaluation of using high power during CLOSE-guided pulmonary vein isolation (PVI) using the Thermocool Smarttouch (Biosense Webster) device—the POWER-AF...
European launch for Acutus Medical’s AcQCross transseptal crossing system
Acutus Medical has announced CE mark approval and the European launch of its integrated family of transseptal crossing products, designed to deliver safe and...
Volta Medical’s VX1 AI software for use in AF mapping now FDA cleared
Volta Medical has announced that it has obtained US Food and Drug Administration (FDA) clearance for its VX1 AI (artificial intelligence) software. According to...
Rhythm AI announces publication of STAR mapping study
Rhythm AI has announced publication of a human clinical outcome study for its Stochastic Trajectory Analysis of Ranked signals (STAR) mapping system in Circulation:...
Adagio closes US$42.5 million Series E financing
Adagio, developer of the intelligent Continuous Lesion Ablation System (iCLAS), has announced that it has closed a US$42.5 million Series E equity financing. Proceeds...
Kardium announces first clinical use of Globe Positioning System
Kardium has announced the first clinical use of the Globe Positioning System—a 3D mapping and navigation feature of its flagship product, the Globe Mapping...
European and Australian approvals granted for Abbott’s cardiac mapping system EnSite
Abbott has announced has announced the receipt of CE mark and approval in Australia for its EnSite X EP System, and is launching the...
Boston Scientific initiates CHAMPION-AF trial of Watchman FLX
Boston Scientific has initiated the CHAMPION-AF clinical trial to evaluate the safety and efficacy of the Watchman FLX left atrial appendage closure (LAAC) device...
First patients treated with the Centauri pulsed electric field system
Galaxy Medical, a developer of pulsed electric field (PEF) technology, has announced that the first patients in the ECLIPSE-AF study were successfully treated with...
Rhythm AI gets green light for ROCSTAR clinical trial
Rhythm AI has today announced that it has received approval from the UK Medicines and Healthcare Products Regulatory Agency (MHRA) to proceed with its...
First patients in Europe treated with Biosense Webster Varipulse catheter
Johnson & Johnson has announced that Biosense Webster has enrolled and treated the first patients in its inspIRE clinical study in Europe. The study...
US FDA approval for second generation AcQMap system
Acutus Medical has announces US Food and Drug Administration (FDA) 510(k) clearance of the second-generation AcQMap 3D imaging and mapping catheter which builds on...
Stereotaxis robotic navigation systems installed in Phoenix and Helsinki
Stereotaxis has completed installations of the world’s first Genesis Robotic Magnetic Navigation (RMN) systems to treat heart rhythm disorders at Helsinki University Hospital in...
Acutus announces pre-clinical results of a novel diagnostic workflow using its AcQMap system
Acutus Medical has announced pre-clinical experimental results of a novel diagnostic and therapeutic workflow utilising the AcQMap system along with tissue-selective, non-thermal pulse field...
ESC Congress 2020: EAST-AFNET 4 finds early rhythm control improves AF outcomes
Patients with newly diagnosed atrial fibrillation benefit from early rhythm control therapy, according to results of the EAST-AFNET 4 trial presented in a Hot...
Biosense Webster launches latest generation of Carto heart mapping system
Johnson & Johnson Medical Devices Companies has today announced the launch of Biosense Webster’s Carto 3 system version 7 and the Carto Prime mapping...
Philips announces new imaging enhancements for Kodex-EPD system
Royal Philips has announced new imaging and workflow enhancements for its Kodex-EPD cardiac imaging and mapping system. The system is used to treat patients...
Using advanced imaging to tackle complex arrhythmias
J Peter Weiss (Heart Institute, Banner University of Arizona Medical Center, Phoenix, USA) outlines his experience of the AcQMap (Acutus Medical) 3D imaging and...
Abbott begins IDE study of TactiFlex device for paroxysmal AF
Abbott has announced first enrolments in the TactiFlex PAF IDE study to evaluate a new device to treat people suffering from paroxysmal atrial fibrillation...
Prompt diagnosis “vital” in effective AF management
Dhiraj Gupta, consultant cardiologist and electrophysiologist at Liverpool Heart and Chest Hospital, (Liverpool, UK) discusses the current burden of atrial fibrillation (AF) on healthcare...
Next-generation Watchman LAAC device gains US FDA approval
Boston Scientific has received US Food and Drug Administration (FDA) approval for the Watchman FLX left atrial appendage closure (LAAC) device. The device is...
Athena Poppas
Athena Poppas is chief of cardiology at the Alpert Medical School of Brown University (Providence, USA) and has recently begun her term as the...
NuVera announces successful first-in-human use of NuVision ICE catheter
NuVera Medical has announced the initiation of the company's first-in-human clinical trial to evaluate the performance of its NuVision intracardiac echocardiography (ICE) catheter. The...
€3.7m funding round completed for cardiac AI developer inHEART
inHEART, developer of a cloud-based medical image analysis solution for cardiac interventions on patients with arrhythmias, has closed a funding round of €3.7m led...
Carag Bioresorbable Septal Occluder approved for US IDE trial
US Food and Drug Administration (FDA) Investigational Device Exemption (IDE) approval has been granted for the Carag Bioresorbable Septal Occluder (CBSO).
The CE-marked CBSO is...
Occupation: Influencer
Jeffrey L Turner, Brian Zenger and Benjamin Steinberg (all University of Utah School of Medicine, Salt Lake City), write that social media has become...
HRS 2020 Science: Packer assesses CABANA’s legacy
As part of this year’s HRS 2020 Science virtual event Douglas L Packer (Mayo Clinic, Rochester, USA) delivered the 2020 Eric N Prystowsky lecture...
Boston Scientific launches its DirectSense technology in the USA
Boston Scientific has announced the US launch of DirectSense technology, a tool for monitoring the effect of radiofrequency (RF) energy delivery during cardiac ablation...
Acutus Medical and Biotronik announce electrophysiology alliance
Acutus Medical and Biotronik have announced a new alliance to provide a comprehensive portfolio of electrophysiology, mapping, ablation and accessory products for catheter-based treatment...
CONVERGE IDE trial results presented at HRS 2020 Science
AtriCure has announced results from the CONVERGE IDE clinical trial, which showed an 18% difference in favour of the hybrid Convergent procedure as compared...
Boston Scientific announces positive PINNACLE FLX study results
Boston Scientific has announced positive 12-month results from the PINNACLE FLX clinical trial assessing the safety and efficacy of the next-generation WATCHMAN FLX Left...
Results of PULSED AF trial presented at HRS 2020 Science
Initial results of the PULSED AF trial, the first-in-human results for paroxysmal or persistent atrial fibrillation (AF) treated with pulsed field ablation (PFA) were...
Daniel M Philbin Jr named new chair of the ACC board of governors
Daniel M Philbin Jr has been named chair of the American College of Cardiology (ACC) board of governors and secretary of the board of...
Virtual ACC: Mavacamten “promising” in treatment of non-obstructive hypertrophic cardiomyopathy
Results from the phase 2 MAVERICK-HCM clinical trial, presented at the American College of Cardiology/World Congress of Cardiology’s virtual scientific sessions (ACC.20/WCC Virtual) suggest that...
BCIS and BCS ratify NHS guidance for cardiology during COVID-19 pandemic
The British Cardiovascular Intervention Society (BCIS) and the British Cardiovascular Society (BCS) have endorsed guidance published by NHS England and NHS Improvement on the...
Portola Pharmaceuticals unveils data on Andexxa in patients with multiple types of Factor Xa...
Portola Pharmaceuticals announced new data that they say reinforces the value of Andexxa (coagulation factor Xa , inactivated-zhzo). The company statement outlines that the...
Stereotaxis receives FDA clearance for Genesis Robotic Magnetic Navigation system
Stereotaxis has received US Food and Drug Administration (FDA) 510(k) clearance for the Genesis Robotic Magnetic Navigation (RMN) system for the robotic navigation of...
EHRA 2020 to feature late-breaking arrhythmia studies
Twenty late-breaking trials, including major clinical studies on the treatment of atrial fibrillation (AF) are among the research to be presented at the annual...
Kalyanam Shivkumar named as editor-in-chief of JACC: Clinical Electrophysiology
Kalyanam Shivkumar has been named the next editor-in-chief of the Journal of the American College of Cardiology (JACC): Clinical Electrophysiology.
Shivkumar is a physician scientist...
CardioFocus submits HeartLight X3 PMA application to FDA
CardioFocus has submitted a pre-market approval (PMA) supplement to the US Food and Drug Administration (FDA) for the HeartLight X3 Endoscopic Ablation System for...
AF Symposium 2020: Use-as-needed NOAC strategy is safe and effective for selected AF patients
Speaking today at the AF Symposium (23–25 January, Washington, DC, USA), Francis Marchlinski (Hospital of the University of Pennsylvania, Philadelphia, USA) reported that selected...
Medtronic gains FDA approval for PulseSelect trial
Medtronic has received approval from the US Food and Drug Administration (FDA) to proceed with an investigational device exemption (IDE) trial to evaluate the...
AI and its growing role in arrhythmia
Malcom Finlay (Bart's Health Centre, London, UK) reviews the growing role of artificial intelligence (AI) in diagnosing arrhythmias.
Johnny, a 72-year-old film producer, is meeting...
CardioFocus appoints Burke T Barrett as chief executive
CardioFocus, has announced that the company’s board of directors has promoted Burke T Barrett to the position of chief executive officer (CEO), effective January...
